Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

May Tun Saung

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Therapeutics|September 24, 2017
Current Standards of Chemotherapy for Pancreatic CancerMay Tun Saung, Lei Zheng
Annals of Pancreatic Cancer|May 15, 2020
Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinomaMay Tun Saung, Lei Zheng
Journal for Immunotherapy of Cancer|August 24, 2019
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escapeArsen Osipov, May Tun Saung, Lei Zheng, et al.
Biomaterials Science|September 19, 2019
Particulate carrier systems as adjuvants for cancer vaccinesMay Tun Saung, Xiyu Ke, Gregory P Howard, et al.
Cancer Letters|December 3, 2020
CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinomaStephen T Muth, May Tun Saung, Alex B Blair, et al.
International Journal of Pharmaceutics|May 27, 2025
A nanoparticle platform for the co-delivery of multiple antigen epitope peptides and STING agonist to lymph nodes for cancer immunotherapyXiyu Ke, Brady A Campbell, Xiaoya Lu, et al.
Advanced Drug Delivery Reviews|October 19, 2019
Physical and chemical profiles of nanoparticles for lymphatic targetingXiyu Ke, Gregory P Howard, Haoyu Tang, et al.
Investigative Radiology|July 7, 2012
Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrastMerav Weill Galper, May Tun Saung, Valentin Fuster, et al.
Journal for Immunotherapy of Cancer|November 15, 2018
Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancerMay Tun Saung, Stephen Muth, Ding Ding, et al.
The Oncologist|May 11, 2021
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with SorafenibMay Tun Saung, Lorraine Pelosof, Sandra Casak, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Therapeutics|September 24, 2017
Current Standards of Chemotherapy for Pancreatic CancerMay Tun Saung, Lei Zheng
Annals of Pancreatic Cancer|May 15, 2020
Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinomaMay Tun Saung, Lei Zheng
Journal for Immunotherapy of Cancer|August 24, 2019
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escapeArsen Osipov, May Tun Saung, Lei Zheng, et al.
Biomaterials Science|September 19, 2019
Particulate carrier systems as adjuvants for cancer vaccinesMay Tun Saung, Xiyu Ke, Gregory P Howard, et al.
Cancer Letters|December 3, 2020
CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinomaStephen T Muth, May Tun Saung, Alex B Blair, et al.
International Journal of Pharmaceutics|May 27, 2025
A nanoparticle platform for the co-delivery of multiple antigen epitope peptides and STING agonist to lymph nodes for cancer immunotherapyXiyu Ke, Brady A Campbell, Xiaoya Lu, et al.
Advanced Drug Delivery Reviews|October 19, 2019
Physical and chemical profiles of nanoparticles for lymphatic targetingXiyu Ke, Gregory P Howard, Haoyu Tang, et al.
Investigative Radiology|July 7, 2012
Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrastMerav Weill Galper, May Tun Saung, Valentin Fuster, et al.
Journal for Immunotherapy of Cancer|November 15, 2018
Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancerMay Tun Saung, Stephen Muth, Ding Ding, et al.
The Oncologist|May 11, 2021
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with SorafenibMay Tun Saung, Lorraine Pelosof, Sandra Casak, et al.
Pageof 2